Acute cerebellar infarction associated with intravenous gammaglobulin treatment in idiopathic thrombocytopenic purpura.

[1]  S. Jordan,et al.  Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[2]  A. Daif,et al.  Thrombosis complicating high dose intravenous immunoglobulin: report of three cases and review of the literature , 2003, European journal of neurology.

[3]  M. Cartwright,et al.  The clinical features of 16 cases of stroke associated with administration of IVIg , 2003, Neurology.

[4]  D. Okuda,et al.  Arterial thrombosis induced by IVIg and its treatment with tPA , 2003, Neurology.

[5]  A. Bogdanović,et al.  Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in adult chronic ITP. , 2003, The hematology journal : the official journal of the European Haematology Association.

[6]  A. Sreih,et al.  Thrombotic Complications After Intravenous Immunoglobulin Therapy in Two Patients , 2002, Pharmacotherapy.

[7]  M. Dalakas.  High‐dose intravenous immunoglobulin and serum viscosity , 1994, Neurology.

[8]  W. Reinhart,et al.  Effect of high-dose intravenous immunoglobulin therapy on blood rheology , 1992, The Lancet.

[9]  M. Greaves,et al.  Plasma D‐dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states , 1989, British journal of haematology.

[10]  A. Grigg,et al.  FATAL THROMBOTIC EVENTS DURING TREATMENT OF AUTOIMMUNE THROMBOCYTOPENIA WITH INTRAVENOUS IMMUNOGLOBULIN IN ELDERLY PATIENTS , 1986, The Lancet.